These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26535126)

  • 21. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class.
    Webster LR; Brewer RP; Lichtlen P; Losch-Beridon T; Mareya S; Wang M
    Pain Med; 2018 Jun; 19(6):1195-1205. PubMed ID: 29897589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of naloxegol in the management of opioid-induced bowel dysfunction.
    Leppert W; Woron J
    Therap Adv Gastroenterol; 2016 Sep; 9(5):736-46. PubMed ID: 27582887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Randomized, Multicenter, Prospective, Crossover, Open-Label Study of Factors Associated With Patient Preferences for Naloxegol or PEG 3350 for Opioid-Induced Constipation.
    Brenner DM; Hu Y; Datto C; Creanga D; Camilleri M
    Am J Gastroenterol; 2019 Jun; 114(6):954-963. PubMed ID: 31058652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT/QTc study in healthy volunteers.
    Gottfridsson C; Carlson G; Lappalainen J; Sostek M
    Clin Ther; 2013 Dec; 35(12):1876-83. PubMed ID: 24238792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: a 3-month follow-up analysis.
    Cobo Dols M; Beato Zambrano C; Cabezón Gutiérrez L; Chicas Sett R; Blancas López-Barajas MI; García Navalón F; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Jiménez López AJ; Huerta González I; Sanz Yagüe A; Soler López B
    BMJ Support Palliat Care; 2021 Mar; 11(1):25-31. PubMed ID: 32376758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study.
    Cobo Dols M; Beato Zambrano C; Cabezón-Gutiérrez L; Chicas-Sett R; Blancas López-Barajas MI; García Navalón FJ; Fírvida Pérez JL; Serrano Bermúdez G; Togores Torres P; Delgado Mingorance I; Giraldo Marín A; Librán Oriol A; Paredes Lario A; Sánchez Mauriño P; Higuera Gómez O; Moreno Muñoz D; Huerta González I; Sanz-Yagüe A; Soler López B
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e318-e326. PubMed ID: 33707299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Lubiprostone in Patients with Opioid-Induced Constipation: Phase 3 Study Results and Pooled Analysis of the Effect of Concomitant Methadone Use on Clinical Outcomes.
    Spierings ELH; Drossman DA; Cryer B; Mazen Jamal M; Losch-Beridon T; Mareya SM; Wang M
    Pain Med; 2018 Jun; 19(6):1184-1194. PubMed ID: 29016868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid-induced constipation, use of laxatives, and health-related quality of life.
    Christensen HN; Olsson U; From J; Breivik H
    Scand J Pain; 2016 Apr; 11():104-110. PubMed ID: 28850447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review of Naldemedine and Naloxegol for the Treatment of Opioid-Induced Constipation in Cancer Patients.
    Braun UK; Jackson LK; Garcia MA; Imam SN
    Pharmacy (Basel); 2024 Mar; 12(2):. PubMed ID: 38525728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naldemedine is effective in the treatment of opioid-induced constipation in patients with chronic non-cancer pain who had a poor response to laxatives.
    Hale ME; Wild JE; Yamada T; Yokota T; Tack J; Andresen V; Drewes AM
    Therap Adv Gastroenterol; 2021; 14():17562848211032320. PubMed ID: 34377150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic Profile of Naloxegol, a Peripherally Acting
    Floettmann E; Bui K; Sostek M; Payza K; Eldon M
    J Pharmacol Exp Ther; 2017 May; 361(2):280-291. PubMed ID: 28336575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the Safety and Efficacy of Naloxegol in Critically Ill Opioid-Induced Constipation Patients.
    Rizwan MZ; Garcia R; Mara K; Nei S
    Cureus; 2023 Jul; 15(7):e41422. PubMed ID: 37546147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New Formulation of Sustained Release Naloxone Can Reverse Opioid Induced Constipation Without Compromising the Desired Opioid Effects.
    Sanders M; Jones S; Löwenstein O; Jansen JP; Miles H; Simpson K
    Pain Med; 2015 Aug; 16(8):1540-50. PubMed ID: 26110375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population Exposure-Response Modeling Supported Selection of Naloxegol Doses in Phase III Studies in Patients With Opioid-Induced Constipation.
    Al-Huniti N; Xu H; Zhou D; Aksenov S; Fox R; Bui KH
    CPT Pharmacometrics Syst Pharmacol; 2017 Oct; 6(10):705-711. PubMed ID: 28782266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Oral Therapies for Opioid-induced Bowel Dysfunction in Patients with Chronic Noncancer Pain.
    Holder RM; Rhee D
    Pharmacotherapy; 2016 Mar; 36(3):287-99. PubMed ID: 26945548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
    Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
    J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time.
    Coyne KS; Margolis MK; Yeomans K; King FR; Chavoshi S; Payne KA; LoCasale RJ
    Pain Med; 2015 Aug; 16(8):1551-65. PubMed ID: 25802051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.